A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1

Clinical trial NCT01897701 · COMPLETED

Trial details

NCT number: NCT01897701
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Avian Influenza

Start date: 2013-07-01
Primary completion: 2014-08-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.